Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Merck & Co. synthesizes orexin OX2 receptor agonists

July 18, 2022

Novartis divulges new cGAS inhibitors

July 18, 2022

GlaxoSmithKline synthesizes new Nav1.8 channel blockers

July 15, 2022

Pandeia Therapeutics patents new GPR88 agonists

July 15, 2022

UCB SA patents DRD1 PAMs

July 14, 2022

"Master sites" trigger cascade of tau phosphorylation in Alzheimer's disease

July 13, 2022

MJFF grant supports evaluation of EpicentRx's NLRP3 inflammasome inhibitor for Parkinson's

July 13, 2022

UCB SA divulges new DRD1 PAMs

July 12, 2022

Gritscience Biopharmaceuticals describes new casein kinase inhibitors

July 11, 2022

H. Lundbeck A/S discloses new NMDA glycine-site receptor modulators

July 11, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 18, 2026.
ASGCT 2026: Directed evolution in gene therapy
BioWorld
Directed evolution has become a central pillar in gene therapy. This engineering strategy enables the generation of more efficient variants of genetic editors and...
News in brief
BioWorld Asia
BioWorld Asia briefs for May 19, 2026
NTX-819, a novel mGlu7 NAM for psychiatric disorders
BioWorld Science
Increasing evidence supports metabotropic glutamate mGlu7 receptor as a promising target in psychiatric disorders. Neurosterix Pharma Sarl has presented data on...
Authorities work to quickly sequence Ebola species in latest outbreak
BioWorld
If the recent hantavirus outbreak wasn’t enough to keep public health officials busy, a new Ebola virus disease outbreak has been confirmed by authorities in the...